Our results showed that LPS-treated BMDCs did not exhibit any changes in MHC-2 and CD86 surface expression, while BMDC stimulation with B16F10 and MOC2 tumor cell lysates resulted in differential MHC-2 expression in response to ISO treatment (as shown in Figure S3). The gene discussed is CD86; the disease is neoplasm.